Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 22Terminated 8Active not recruiting 6Unknown 4Recruiting 3Withdrawn 1Suspended 1

Sponsor Class

OTHER 39INDUSTRY 3OTHER_GOV 1NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Myeloid, Acute 3

Interventions

pembrolizumab 241Carboplatin 170Injections 139Paclitaxel 122Gemcitabine 118Bevacizumab 117Cisplatin 108Pemetrexed 80Docetaxel 80Cyclophosphamide 74Capecitabine 69Fluorouracil 67Oxaliplatin 65Fulvestrant 60Nivolumab 55Cetuximab 53fludarabine 52Leucovorin 51130-nm albumin-bound paclitaxel 50Dexamethasone 46Rituximab 41atezolizumab 38venetoclax 35toripalimab 35Drug Therapy 35enzalutamide 32Prednisone 32Letrozole 32Irinotecan 32durvalumab 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Decitabine × Clear all
NCT05586074 2026-04-28

HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML

Sunshine Lake Pharma Co., Ltd.

Phase 3 Recruiting
324 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05190471 2025-03-10

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

Bio-Path Holdings, Inc.

Phase 1 Recruiting
48 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02781883 2025-03-07

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

Bio-Path Holdings, Inc.

Phase 2 Recruiting
108 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡